France's Innopsys Says Array Scanner Sales Rose 25 Percent in '09; Firm Plans US Marketing Effort | GenomeWeb

By Justin Petrone

Innopsys, a French microarray scanner and software maker, this week reported a 25-percent spike in 2009 receipts and a 30-percent increase in first-quarter sales.

The privately held company, based in Carbonne, said it expects total 2010 revenue to increase 30 percent to $2.6 million as it focuses on the US market.

For the 12 months ended Dec. 31, 2009, Innopsys' revenues rose 25 percent to $2 million from $1.6 million in 2008.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.